All In Biotech

Drug Trial Radar · NCT06396416

Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2

Obesity Management for Kidney TRANSPLANTation: a Vanguard Study for an Innovative Randomized Controlled Trial, Embedded in Routine Care (OK-TRANSPLANT 2)

Last checked: Nov 20, 2026Latest source record: Jun 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

60

Planned (sponsor's estimate)

Start

Sep 26, 2024

Primary completion

Sep 30, 2026

Study completion Dec 2026

Sponsor

Lead sponsor
Western University, CanadaAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's; Queen Elizabeth II Health Sciences Centre; Unity Health Toronto
First posted
May 2, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (investigator, outcomes assessor)
Primary purpose
Other
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

OK-TRANSPLANT 2 is a vanguard study for a large randomized, pragmatic, open-label trial. We will randomize participants with obesity, high-risk CKD/dialysis who are hoping for lose weight for the purpose of kidney transplant. Subjects will either be enrolled on a virtual weight management program or continue their usual care.

Conditions

  • Obesity
  • Chronic Kidney Disease

Interventions

  • SemaglutideDrug

    Maximum tolerated dose of semaglutide subcutaneously once weekly. Maximum dose of 2.0 mg.

  • Virtual Weight Management CoachingBehavioral

    Virtual meeting with intervention coach once every 4 weeks for 6 months, where the coach will discuss the goals and progress with participant, nutritional advice, exercise advice, and motivational support.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Feasibility of RecruitmentTime frame: 12 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • London Health Sciences Centre

    London, Ontario, Canada · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.